Intake of Pro- and/or Prebiotics as a Promising Approach for Prevention and Treatment of Colorectal Cancer

被引:5
|
作者
Wang, Huijuan [1 ,2 ]
Chen, Ke [1 ,2 ]
Ning, Mengge [1 ,2 ]
Wang, Xin [1 ,2 ]
Wang, Zhouli [1 ,2 ]
Yue, Yuan [4 ]
Yuan, Yahong [1 ,2 ]
Yue, Tianli [1 ,2 ,3 ]
机构
[1] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Peoples R China
[2] Minist Agr, Lab Qual & Safety Risk Assessment Agriprod Yanglin, Yangling 712100, Peoples R China
[3] Northwest Univ, Coll Food Sci & Technol, Xian 710069, Peoples R China
[4] Xian Gaoxin 1 High Sch, Xian 71000, Peoples R China
关键词
colorectal cancer; gut microbiota; pro-; and; or prebiotic interventions; DSS-INDUCED COLITIS; GUT MICROBIOTA; LACTOBACILLUS-PLANTARUM; COLON-CANCER; PPAR-GAMMA; METABOLITE BUTYRATE; DIETARY FIBER; FATTY-ACIDS; SHORT-CHAIN; PROBIOTICS;
D O I
10.1002/mnfr.202200474
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
BackgroundColorectal cancer (CRC) is the third most common type of cancer, posing a serious threat to human life. It is widely believed that dietary factors may be crucial modifiers of CRC risk, with pro-and/or prebiotics being especially promising. ScopeIn this review, a synthesis of CRC prevention and treatment of strategies relying on usage of pro- and/or prebiotics supplements is given, as well as discuss mechanisms underlying the contribution of pro-and/or prebiotics to the suppression of colonic carcinogenesis. Furthermore, a framework for personalizing such supplements according to the composition of an individual's gut microbiome is suggested. ConclusionsVarious factors including diversity of one's intestinal microflora, integrity of their intestinal barrier, and the presence of mutagenic/carcinogenic/genotoxic and beneficial compounds are known to have a prominent influence on the development of CRC; thus, clarifying the role of pro- and/or prebiotics will yield valuable insight toward optimizing interventions for enhanced patient outcomes in the future.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Prevention of allergy by pro- and prebiotics
    Grueber, Christoph
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (01) : 1 - 3
  • [2] The custom clearance of pro- and prebiotics in allergy prevention
    Fiocchi, Alessandro
    Fierro, Vincenzo
    La Marra, Fabiola
    Dahdah, Lamia Antanios
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : 465 - 467
  • [3] Prevention and Control of Diseases by Use of Pro- and Prebiotics (Synbiotics)
    Shafi, Afshan
    Farooq, Umar
    Akram, Kashif
    Hayat, Zafar
    Murtaza, Mian Anjum
    FOOD REVIEWS INTERNATIONAL, 2014, 30 (04) : 291 - 316
  • [4] Probiotics, prebiotics and colorectal cancer prevention
    Ambalam, Padma
    Raman, Maya
    Purama, Ravi Kiran
    Doble, Mukesh
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (01) : 119 - 131
  • [5] Probiotics and prebiotics: a food-based approach in the prevention of colorectal cancer
    Telang, J
    Shah, NP
    Vasiljevic, T
    MILCHWISSENSCHAFT-MILK SCIENCE INTERNATIONAL, 2005, 60 (03): : 241 - 245
  • [6] Potential role of probiotics and prebiotics for the prevention of colorectal cancer
    Pool-Zobel, BL
    VITAMINS AND ADDITIVES IN HUMAN AND ANIMAL NUTRITION, 1997, : 62 - 69
  • [7] The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review
    Moreira, Mariana Melo
    Carrico, Marta
    Capelas, Manuel Luis
    Pimenta, Nuno
    Santos, Teresa
    Ganhao-Arranhado, Susana
    Makitie, Antti
    Ravasco, Paula
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Selenium-Rich Foods: a Promising Approach to Colorectal Cancer Prevention
    Hu, Ying
    McIntosh, Graeme H.
    Young, Graeme P.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (01) : 165 - 172
  • [9] Pre-, pro- and synbiotics in cancer prevention and treatment-a review of basic and clinical research
    Scott, Alasdair J.
    Merrifield, Claire A.
    Younes, Jessica A.
    Pekelharing, Elizabeth P.
    ECANCERMEDICALSCIENCE, 2018, 12
  • [10] Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms
    Honari, Mohadese
    Shafabakhsh, Rana
    Reiter, Russel J.
    Mirzaei, Hamed
    Asemi, Zatollah
    CANCER CELL INTERNATIONAL, 2019, 19 (1)